SCHEMBL25856125

SCHEMBL25856125

C1NCC1CN1CCC2(CC1)CNC2

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CHRM5 P08912 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25026748 0.81 TSHR (0.32) TSHRCYP2D6
SCHEMBL30121551 0.81 GBA1 (0.39) TSHRCYP3A4CYP2D6CHRM5ADRA2C
SCHEMBL29317070 0.79 ACHE (0.35) TSHR
SCHEMBL25571573 0.79 TSHR (0.38) TSHR
SCHEMBL30121180 0.79 CHRM5 (0.35) TSHRCHRM5ADRA2C
SCHEMBL24480651 0.78 NCF1 (0.38) TSHRCHRM5ADRA2C
SCHEMBL25571652 0.78 CHRM5 (0.40) CHRM5ADRA2C
SCHEMBL25324905 0.78 JAK2 (0.33) CHRM5ADRA2C
SCHEMBL3061830 0.73
SCHEMBL20881807 0.73 CHRM5 (0.54) CHRM5ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed